A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

Inclusion Criteria: * Must meet at least 3 of the following criteria for treatment in the face with at least 2 JUVÉDERM products, per investigator's assessment: * Minimal, moderate, or severe on Allergan Temple Hollowing Scale (ATHS) * Moderate or severe for both eyes on Allergan Infraorbital Hollow Scale (AIHS) * Moderate or severe on Allergan Cheek Smoothness Scale (ACSS) * Moderate, significant, or severe on Mid-face Volume Deficit Scale (MFVDS) * Moderate or severe on Nasolabial Fold Severity Scale (NLFSS) * Minimal, mild, or moderate on Allergan Lip Fullness Scale 2 (ALFS2) * Moderate or severe on Allergan Chin Retrusion Scale (ACRS) * Moderate or severe on Allergan Loss of Jawline Definition Scale (ALJDS) * Must be in good health as determined by subject's medical history, physical examination, and vital sign measurements. Exclusion Criteria: * Prior treatment with non-permanent soft tissue fillers or fat-reducing injectables in the face or neck within 12 months prior to screening. * Excessively loose skin in the face and/or neck. * Tendency to develop hypertrophic scarring and/or keloid scarring.